Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India flag India · Delayed Price · Currency is INR
620.55
-9.85 (-1.56%)
Nov 12, 2026, 3:29 PM IST

NSE:NEPHROPLUS Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,281768.4670.96351.33-117.89-219.75
Depreciation & Amortization
979.08886.49719.18540.19465.16389.03
Other Amortization
8.368.365.518.663.633.69
Loss (Gain) From Sale of Assets
12.9212.76-0.65--
Asset Writedown & Restructuring Costs
14.412.714.2612.28-27.68
Loss (Gain) From Sale of Investments
-91.35-91.35-7.55---
Loss (Gain) on Equity Investments
105.7430.93----
Stock-Based Compensation
75.4295.1463.818.6420.875.4
Provision & Write-off of Bad Debts
320.09237.7888.57114.8966.6883.28
Other Operating Activities
-199.22420.98250.476.18207.48-5.45
Change in Accounts Receivable
-299.46-687.94-667.31-505.6-543.04-234.48
Change in Inventory
-116.82-54.930.679.7-108.3816.99
Change in Accounts Payable
307.78328.07398.71183.68135.4511.48
Change in Other Net Operating Assets
440.99358.39-173.8-17.8-17.2741.31
Operating Cash Flow
2,8392,3261,353722.8112.69119.18
Operating Cash Flow Growth
-71.84%87.25%541.41%-5.45%-63.39%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-947.81-1,189-997.75-773.49-715.69-429.7
Sale of Property, Plant & Equipment
2.792.22----
Cash Acquisitions
-925.25-503.99-125.41-281.37-64.17-626.82
Sale (Purchase) of Intangibles
-5.6-4.26-10.22-26.52-21.69-3.51
Investment in Securities
-1,453-1,49647.27459.66-46.03-642.23
Other Investing Activities
118.93-913.27-164.62115.1265.5227.38
Investing Cash Flow
-3,210-4,104-1,251-506.6-782.06-1,675

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--81.0513.73620.78-
Long-Term Debt Issued
---723.68388.61184.03
Total Debt Issued
241.81-81.05737.411,009184.03
Short-Term Debt Repaid
--878.86----189.9
Long-Term Debt Repaid
--1,267-328.91-310.52-238.81-224.65
Lease Payments
-140.03-118.25-76.65-56.85-38.31-16.55
Total Debt Repaid
-1,655-2,146-328.91-310.52-238.81-414.55
Net Debt Issued (Repaid)
-1,414-2,146-247.86426.89770.58-230.53
Issuance of Common Stock
3,2703,902979.655.5823.631,811
Other Financing Activities
-234.51-184.78-188.08-165.08-194.55-111.98
Financing Cash Flow
1,6221,571543.71267.39599.661,474

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
51.35188.190.21-12.6824.8-
Net Cash Flow
1,302-19.28646.66470.91-44.91-81.95

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
1,8911,136355.72-50.69-603-310.52
Free Cash Flow Growth
-219.47%----
Free Cash Flow Margin
16.96%11.38%4.71%-0.90%-13.79%-9.80%
Free Cash Flow Per Share
18.7411.984.25-0.63-7.83-37.45
Levered Free Cash Flow
-913.5110.9920.41-1,417-279.76
Unlevered Free Cash Flow
-1,276228.91139.16-1,326-219.18
Free Cash Flow After Leases
1,7511,018279.07-107.54-641.31-327.06

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
184.78184.78188.1165.08161.1396.66
Cash Income Tax Paid
274.77274.779.5780.63-46.2147.94
Change in Working Capital
332.49-56.41-441.73-330.02-533.24-164.7